The four-day must-attend event in Boston in June will explore ways in which diversity, innovation, and AI are accelerating the future of health

DIA, the premier professional global community for healthcare product development, will host its 2023 Global Annual Meeting in Boston, June 25-29. In keeping with this year's theme, “Illuminate,” the event underscores the importance of convening global sponsors, CROs, regulators, academics, and patients face-to-face for honest and open collaboration that illuminates the path to the future of healthcare and ignites critical change in drug, device, and diagnostic development.

“For more than 50 years, DIA has played a key role in the global drug development industry ecosystem but there’s so much more we must do,” said Marwan Fathallah, DIA’s recently named President and Global Chief Executive. “The innovative spirit of the 2023 Global Annual Meeting brings together the world’s top scientific minds, industry leaders, regulators, and public policy influencers in one place to share meaningful, revolutionary insights on the challenges that lie ahead. As we emerge from the COVID-19 pandemic, we see the dawning of a new day in clinical development. We have opportunities to transform the industry as we know it for the benefit of patients everywhere.”

This year, the meeting’s opening keynote plenary and panel discussion will be led by Dr. Junaid Bajwa, the Chief Medical Scientist at Microsoft Research, and a practicing physician in the UK’s National Health Service. The discussion will focus on how diversity, innovation, and artificial intelligence (AI) are transforming the life sciences industry.

On track to be one of DIA’s largest events, with more than 5,000 attendees and 500+ speakers, the Global Annual Meeting is the preeminent industry-neutral forum for the entire international healthcare value chain ranging from policy and regulation to research and development, marketing, and access. Meeting participants are afforded unique access to top executives, scientific minds, regulators, academics, and patient advocates from Africa, Asia, Europe, North America, and South America to collaboratively explore and problem-solve some of the biggest issues facing the industry – from diversity, equity, and inclusion and decentralized clinical trials (DCT) to AI and advances in oncology.

DIA’s 2023 Global Annual Meeting includes over 170 sessions spanning across 13 educational tracks. Highly anticipated sessions at the event include:

• Revolutionizing Life Sciences: How Diversity, Innovation and AI are Accelerating the Future of Health – This plenary will illuminate major industry disruptors and their impact on clinical development.
• WHO Town Hall – An update will be given by WHO and perspectives from some of the newly designated WHO-Listed Authorities (WLA) on main principles and expected global benefits of the new WLA framework.
• FDA Town Hall and FDA Rare Disease Town Hall – Offers unique in-person exchange and dialogue with FDA leaders to inspire innovative solutions to 2023’s life sciences challenges.
• China, Asia, ANVISA, and Health Canada Town Halls – Explore the future of clinical trials and drug development in these regions, as well as the latest efforts for regulatory convergence.
• Professional Development – One of DIA’s most attended tracks, the professional development sessions explore “soft skills” such as interpersonal skills, leadership, goal setting, life-long learning, career transitions, social media, and self-awareness to help attendees assess their strengths and gaps.

Learn more about DIA's 2023 Global Annual Meeting by exploring the searchable event program, and by registering for the event here.

About DIA

DIA (founded as the Drug Information Association) is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers, and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow. As a member-driven, volunteer organization, professionals from 80 countries have affected healthcare outcomes by engaging with DIA through an unparalleled network, educational offerings, and professional development opportunities. DIA is based in Washington, DC (US) with regional offices representing the Americas (Horsham, PA, US); Europe, the Middle East, and Africa, (Basel, Switzerland); and Asia (Beijing and Shanghai, China; Mumbai, India; and Tokyo, Japan).

For live updates, search social media with #DIA2023, and connect with DIA on Twitter, LinkedIn, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230601005812/en/